On Monday, Biohaven Ltd (NYSE: BHVN) opened higher 7.72% from the last session, before settling in for the closing price of $38.47. Price fluctuations for BHVN have ranged from $26.80 to $62.21 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -53.58% at the time writing. With a float of $88.62 million, this company’s outstanding shares have now reached $94.90 million.
Let’s look at the performance matrix of the company that is accounted for 239 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Biohaven Ltd (BHVN) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Biohaven Ltd is 12.36%, while institutional ownership is 86.11%. The most recent insider transaction that took place on Oct 02 ’24, was worth 999,970. In this transaction Director of this company bought 21,052 shares at a rate of $47.50, taking the stock ownership to the 21,052 shares. Before that another transaction happened on Oct 02 ’24, when Company’s Chief Executive Officer bought 21,052 for $47.50, making the entire transaction worth $999,970. This insider now owns 861,942 shares in total.
Biohaven Ltd (BHVN) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -53.58% per share during the next fiscal year.
Biohaven Ltd (NYSE: BHVN) Trading Performance Indicators
Check out the current performance indicators for Biohaven Ltd (BHVN). In the past quarter, the stock posted a quick ratio of 2.89.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -9.35, a number that is poised to hit -1.60 in the next quarter and is forecasted to reach -6.24 in one year’s time.
Technical Analysis of Biohaven Ltd (BHVN)
Biohaven Ltd (NYSE: BHVN) saw its 5-day average volume 1.18 million, a positive change from its year-to-date volume of 1.12 million. As of the previous 9 days, the stock’s Stochastic %D was 17.74%. Additionally, its Average True Range was 2.80.
During the past 100 days, Biohaven Ltd’s (BHVN) raw stochastic average was set at 38.53%, which indicates a significant decrease from 42.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.36% in the past 14 days, which was higher than the 57.70% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $48.61, while its 200-day Moving Average is $43.43. Nevertheless, the first resistance level for the watch stands at $43.48 in the near term. At $45.52, the stock is likely to face the second major resistance level. The third major resistance level sits at $48.91. If the price goes on to break the first support level at $38.05, it is likely to go to the next support level at $34.66. Assuming the price breaks the second support level, the third support level stands at $32.62.
Biohaven Ltd (NYSE: BHVN) Key Stats
There are currently 101,122K shares outstanding in the company with a market cap of 4.01 billion. Presently, the company’s annual sales total 0 K according to its annual income of -408,170 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -160,300 K.
